Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Ani Pharmaceuticals (ANIP) over the last 12 years, with Q3 2025 value amounting to $32.6 million.

  • Ani Pharmaceuticals' Treasury Shares rose 20790.57% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 20790.57%. This contributed to the annual value of $21.0 million for FY2024, which is 10870.95% up from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Treasury Shares is $613972.0, which was down 5887.66% from $602000.0 recorded in Q2 2025.
  • Ani Pharmaceuticals' Treasury Shares' 5-year high stood at $1.5 million during Q3 2024, with a 5-year trough of $80000.0 in Q2 2021.
  • Over the past 5 years, Ani Pharmaceuticals' median Treasury Shares value was $413000.0 (recorded in 2024), while the average stood at $505554.1.
  • Its Treasury Shares has fluctuated over the past 5 years, first tumbled by 5000.0% in 2021, then surged by 68572.73% in 2023.
  • Quarter analysis of 5 years shows Ani Pharmaceuticals' Treasury Shares stood at $3.1 million in 2021, then skyrocketed by 62.49% to $5.1 million in 2022, then surged by 97.9% to $10.1 million in 2023, then skyrocketed by 108.71% to $21.0 million in 2024, then soared by 55.12% to $32.6 million in 2025.
  • Its Treasury Shares was $32.6 million in Q3 2025, compared to $31.6 million in Q2 2025 and $31.0 million in Q1 2025.